Professional
Added to YB: 2024-06-11
Pitch date: 2024-06-03
BDX [bullish]
Becton, Dickinson and Company
-13.41%
current return
Author Info
No bio for this author
Company Info
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.
Market Cap
$57.3B
Pitch Price
$231.08
Price Target
325.00 (+62%)
Dividend
2.09%
EV/EBITDA
11.95
P/E
34.52
EV/Sales
3.51
Sector
Health Care Equipment and Supplies
Category
special_situation
Becton, Dickinson and Company: Critical Care Business Finds a Nice Home With BD
BDX: Buying Edwards' Critical Care biz for $4.2B, good strategic fit. COVID rev invested in core should lift growth. Alaris is back but share damage unclear. Moat: manufacturing scale, installed base. $325 FVE on 5.5% growth despite risks: commoditization, rivals, Alaris share loss.
Read full article (7 min)